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ABSTRACT Interleukin 4 (IL-4), insulin, and insulin-like
growth factor I (IGF-I) efficiently induced DNA synthesis in the
IL-3-dependent murine myeloid cell lines FDC-P1 and FDC-
P2. Although these factors could not individually sustain
long-term growth of these lines, a combination of IL-4 with
either insulin or IGF-I did support continuous growth. The
principal tyrosine-phosphorylated substrate observed in FDC
cells stimulated with IL-4, previously designated 4PS, was of
the same size (170 kDa) as the major substrate phosphorylated
in response to insulin or IGF-I. These substrates had phos-
phopeptides of the same size when analyzed by digestion with
Staphylococcus aureus V8 protease, and each tightly associated
with the 85-kDa component of phosphatidylinositol 3-kinase
after factor stimulation. IRS-1, the principal substrate phos-
phorylated in response to insulin or IGF-I stimulation in
nonhematopoietic cells, is similar in size to 4PS. However,
anti-IRS-1 antibodies failed to efficiently precipitate 4PS, and
some phosphopeptides generated by V8 protease digestion of
IRS-1 were distinct in size from the phosphopeptides of 4PS.
Nevertheless, IL-4, insulin, and IGF-I were capable of stimu-
lating tyrosine phosphorylation of IRS-1 in FDC cells that
expressed this substrate as a result of transfection. These
rmdings indicate that (i) IL-4, insulin, and IGF-I use signal
transduction pathways in FDC lines that have at least one
major feature in common, the rapid tyrosine phosphorylation
of 4PS, and (it) insulin and IGF-I stimulation of hematopoietic
cell lines leads to the phosphorylation of a substrate that may
be related to but is not identical to IRS-1.
Interleukin 4 (IL-4) is a pluripotent cytokine that is intimately
involved in determining the nature of an immune response to
a given pathogen (reviewed in ref. 1). The cDNAs encoding
both the murine and human IL-4 receptors have been cloned
(2-4). Although there are no consensus sequences in the
receptor that suggest any intrinsic tyrosine kinase activity,
IL-4 does induce striking tyrosine phosphorylation of a
170-kDa protein, designated IL-4-induced phosphotyrosine
substrate (4PS) (5). In a previous study, 4PS was shown to
strongly associate with the 85-kDa subunit (p85) of phospha-
tidylinositol (PI) 3-kinase immediately after IL-4 stimulation
(5). This association is reminiscent of PI 3-kinase interaction
with insulin receptor substrate 1 (IRS-1), which leads to PI
3-kinase activation (6-8). Although functions of the metab-
olites produced by this enzyme are not understood, evidence
suggests that PI 3-kinase association with receptors or on-
cogene products correlates with cell proliferation (reviewed
in ref. 9).
IRS-1, the most prominent substrate phosphorylated in
response to stimulation with insulin or insulin-like growth
factor I (IGF-I), is a hydrophilic protein of 160-185 kDa
(10-13). The cDNAs for rat and mouse IRS-1 have been
cloned (14, 15). The inferred amino acid sequence contains 20
potential tyrosine and 30 potential serine and threonine
phosphorylation sites. Nine putative tyrosine phosphoryla-
tion sites are in YMXM or YXXM motifs (16). Tyrosine
phosphorylation of these motifs is thought to result in asso-
ciation with proteins containing Src homology 2 domains,
such as p85 (reviewed in refs. 9, 17, and 18). The unique
properties of IRS-1 suggest that it could potentially serve as
a docking molecule for many key proteins involved in signal
transduction (14, 16). Since insulin receptor mutants that are
defective for mitogenic signaling do not mediate phosphor-
ylation of IRS-1 (19-22), it has been suggested that IRS-1 is
a crucial component of insulin and IGF-I signaling.
In the present study we demonstrate that insulin and IGF-I
act as mitogens for certain IL-4-responsive hematopoietic
cell lines and that the characteristics ofthe principal substrate
tyrosine-phosphorylated in cells treated with each of these
factors are identical. The relationship between insulin- and
IL-4-mediated signal transduction pathways in these factor-
dependent cell lines is investigated.
MATERIALS AND METHODS
Cell Lines and Growth Assays. The CHO/IR/IRS-1 cells
have been described (7, 22). The IL-3-dependent murine
hematopoietic cell lines FDC-P1 (23) and FDC-P2 (24) were
cultured in RPMI 1640 medium with 10% fetal bovine serum
and 5% WEHI-3B conditioned medium. The FDC-Pl/IRS-1
line was generated by electroporation of the rat IRS-1 ex-
pression vector after selection in the presence histidinol (2
mM) as described (7, 25). Incorporation of [3H]thymidine was
used to quantitate factor-induced DNA synthesis in FDC
lines as described (5). Analysis of long-term growth proper-
ties was performed in RPMI 1640 medium with 10% fetal
bovine serum and recombinant IL-4 (10 nM), insulin (1 ,uM),
or IGF-I (10 nM). Cells (5 x 104 per ml) were plated in growth
medium with one or more factors. They were transferred at
a split ratio of 1:10 biweekly. Cell viability was determined by
trypan blue exclusion.
Immunoprecipitation and Immunoblot Analysis. FDC or
CHO cells were washed and resuspended in Dulbecco's
modified Eagle's medium (DMEM) with 50 ,uM Na3VO4 for
Abbreviations: IGF-I, insulin-like growth factor I; IL, interleukin;
IRS-1, insulin receptor substrate 1; PI, phosphatidylinositol; 4PS,
IL-4-induced phosphotyrosine substrate.
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2 hr. After stimulation with either IL-4 (100 nM), insulin (10
AM), or IGF-I (100 nM) for 10 min at 37°C, cells were lysed
in lysis buffer as described (5). Equal amounts of clarified
FDC lysates (2 mg) or CHO/IR/IRS-1 lysates (0.5-1 mg)
were immunoprecipitated with 20 ul of agarose-conjugated
anti-phosphotyrosine (Upstate Biotechnology, Lake Placid,
NY), anti-p85 (1:500; Upstate Biotechnology), or anti-IRS-1
(1:500; ref. 7) plus 30 Al of protein G-coupled Sepharose.
Immunoprecipitates were washed with lysis buffer, solubi-
lized with Laemmli buffer, boiled, and resolved by SDS/8%
PAGE for immunoblot analysis (5).
Peptide Mapping Using Staphylococcus aureus V8 Protease.
Cells were cultured in serum-free DMEM containing 50 ,uM
Na3VO4 for 2 hr and labeled with [32P]orthophosphoric acid
(500 ,tCi/ml; 1 gCi = 37 kBq) in phosphate-free medium for
4 hr. Untreated or factor-treated cells were lysed in lysis
buffer and immunoprecipitated with anti-phosphotyrosine or
anti-IRS-i. The immunoprecipitates were resolved by
SDS/8% PAGE and the 170-kDa bands (present only in
samples from factor-treated cells) were located by autorad-
iography and excised. Peptides from the 170-kDa bands were
generated by in situ proteolytic cleavage within the stacking
gel (26).
RESULTS
Growth Potential of IL-4, Insulin, and IGF-I in IL-3-
Dependent FDC Lines. IL-4, insulin, and IGF-I each induced
dose-dependent [3H]thymidine incorporation in the myeloid
progenitor lines FDC-P1 and FDC-P2 under serum-free con-
ditions. IL-4, insulin, and IGF-I stimulated half-maximal
responses in FDC-P1 cells at approximately 100 pM, 10 nM,
and 20 pM, respectively (Fig. 1). The maximum level of
[3H]thymidine incorporation achieved by each factor was
similar to that of IL-3, implying that they were capable of
inducing as potent a mitogenic response as IL-3 in FDC-P1
cells. FDC-P2 cells also responded mitogenically to IL-4,
insulin, and IGF-I, with half-maximal responses at 25 pM,
100 nM, and 1 nM, respectively (data not shown). These
results provide evidence that the FDC lines possess cell
surface receptors and intracellular components required to
allow short-term mitogenic signaling through the IL-4, insu-
lin, and IGF-I pathways.
While IL-4, insulin, and IGF-I did stimulate DNA synthe-
sis, they failed to support long-term growth of the FDC cells.
Although cells from both lines survived for over 72 hr in
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FIG. 1. Mitogenic dose-response of FDC-P1 cells to various
growth factors. FDC-P1 cells were incubated for 36 hr in serum-free
medium with various concentrations of IL-4 (L), IL-3 (o), insulin (L),
or IGF-I (v). [3H]Thymidine (0.5 ,uCi per well) was added for 4 hr and
samples were then collected by an automatic harvester. Results are
expressed as counts per minute (cpm) in stimulated samples minus
background cpm.
IGF-I, they did not remain viable when transferred to new
culture dishes containing the same factor. By contrast, a
combination of IL-4 with either insulin or IGF-I yielded
sustained growth ofboth lines. Insulin and IGF-I together did
not support continuous growth of either line. Even after
propagation for over 4 months in medium containing both
IL-4 and insulin, neither line continued to proliferate when
switched to medium containing only one factor.
Relationship of the Tyrosine-Phosphorylated Substrates In-
duced by IL-4, Insulin, and IGF-I in FDC Lines. The capacity
of insulin or IGF-I in combination with IL-4 to allow FDC
cells to grow long-term could reflect either the use of com-
plementing signaling pathways or the surpassing of a thresh-
old response through a common signaling pathway in which
receptor numbers were limiting. To help distinguish between
these two alternatives, we compared the tyrosine phosphor-
ylation patterns induced by the three factors in FDC-P1 and
FDC-P2 cells. In both cell lines, each factor induced rapid
tyrosine phosphorylation of a major band migrating at 170
kDa (Fig. 2). Stimulation with IL-4 also resulted in the
phosphorylation of other less prominent bands in each line,
whereas no other substrates were detected after insulin or
IGF-I treatment. To determine whether the 170-kDa sub-
strates phosphorylated by the three factors were identical, we
performed V8 protease digestion analysis. The phosphopep-
tide patterns of the 170-kDa bands tyrosine-phosphorylated
by IL-4, insulin, or IGF-I were indistinguishable (Fig. 3).
Taken together, these results provide strong evidence that
insulin and IGF-I cause phosphorylation of the IL-4-induced
phosphotyrosine substrate 4PS.
Association of the p85 Subunit of PI 3-Kinase with 4PS in
Response to IL-4, Insulin, and IGF-I Stimulation of FDC
Lines. In a previous study, we observed that PI 3-kinase
activity was greatly enhanced in the phosphotyrosine fraction
of lysates of IL-4-stimulated cells (5). A substantial increase
in the amount of PI 3-kinase activity was also observed in the
FDC-P1
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FIG. 2. Detection of phosphotyrosine-containing proteins in
FDC lines after stimulation with IL-4, insulin, or IGF-I. Quiescent
FDC-P1 and FDC-P2 cells were treated with IL-4, insulin (INS), or
IGF-I as illustrated. Cell lysates were immunoprecipitated with
anti-phosphotyrosine, resolved by SDS/PAGE, transferred to a
poly(vinylidene difluoride) (PVDF) membrane, and probed with
anti-phosphotyrosine. Molecular masses of marker proteins are
indicated in kilodaltons.
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FIG. 3. V8 digestion pattern oftyrosine-phosphorylated 170-kDa
proteins' after factor stimulation of FDC-P2 and CHO/IR/IRS-1
cells. Partial V8 digestion was performed on IL-4-, insulin (INS)-, or
IGF-I-treated [32P]orthophosphate-labeled 170-kDa proteins immu-
noprecipitated with anti-phosphotyrosine (aPtyr) or anti-IRS-1
(aIRS-1) from FDC-P2 and CHO/IR/IRS-1 cells.
phosphotyrosine fraction of lysates of insulin- or IGF-I-
treated FDC-Pi or FDC-P2 cells as determined by the
conversion ofPI to PI 3-phosphate in an in vitro reaction (data
not shown). To more specifically define the interaction of PI
3-kinase with the tyrosine-phosphorylated substrates in-
duced in FDC lines, lysates were first immunoprecipitated
with anti-p85 and then immunoblotted with anti-phosphoty-
rosine. Chinese hamster ovary cells transfected with both the
human insulin receptor and rat IRS-1 (CHO/IR/IRS-1) were
also analyzed for comparison (7, 22). A strong band migrating
A FDC-P1 FDC- P2 CHO/IRI
IRS-1








at 170 kDa was observed when either FDC line was treated
with IL-4, insulin, or IGF-I or when CHO/IR/IRS-1 was
treated with insulin (Fig. 4A). When lysates were immuno-
precipitated with anti-phosphotyrosine and immunoblotted
with anti-p85, the amount of p85 was substantially increased
in the IL-4-, insulin-, or IGF-I-treated FDC and insulin-
stimulated CHO/IR/IRS-1 samples when compared with the
lysates of untreated cells (Fig. 4B). Thus, 4PS strongly
associates with the p85 subunit of PI 3-kinase in response to
insulin, IGF-I, or IL-4 stimulation of hematopoietic cells just
as IRS-1 does in nonhematopoietic cells after insulin stimu-
lation.
Relationship of 4PS to IRS-1. To determine the relationship
of 4PS to IRS-1, lysates from factor-stimulated FDC-P2 and
CHO/IR/IRS-1 cells were immunoprecipitated with a poly-
clonal antibody directed against baculovirus-generated rat
IRS-1 or with anti-phosphotyrosine and subsequently immu-
noblotted with anti-phosphotyrosine (Fig. 5). Although anti-
IRS-1 immunoprecipitated a modest amount of 4PS from
lysates of IL-4- or insulin-treated FDC-P2 cells, it was much
less than that immunoprecipitated by anti-phosphotyrosine.
By contrast, anti-IRS-i immunoprecipitated a much greater
fraction of that recognized by anti-phosphotyrosine from the
insulin-stimulated CHO/IR/IRS-1 lysate. Moreover, when
rabbit antibodies directed against either amino- or carboxyl-
terminal peptides ofrat/mouse IRS-1 (13, 27) were utilized in
similar experiments or for direct immunoblot analysis, 4PS
was not detected whereas IRS-1 was readily observed (data
not shown).
V8 protease digestion analysis was carried out on 4PS
immunoprecipitated with anti-phosphotyrosine from lysates
of IL-4- or insulin-stimulated FDC-P2 cells and on IRS-1
immunoprecipitated with anti-IRS-1 or anti-phosphotyrosine
from insulin-treated CHO/IR/IRS-1 cells. Although the pat-
terns of phosphopeptides derived from 4PS (from FDC-P2
cells) and IRS-1 (from CHO/IR/IRS-1 cells) showed simi-
larities, they were not identical (Fig. 3). While a 34-kDa
peptide as well as other less distinct peptides in the 12- to
24-kDa range were found in digests from both substrates, the
IRS-1 digest contained a prominent 25- to 29-kDa peptide not
found in the 4PS digest (Fig. 3). Although these results further











FIG. 4. Association of the p85 subunit of PI 3-kinase with 4PS in FDC lines after stimulation with IL-4, insulin (INS), or IGF-I. (A) Lysates
of IL-4-, insulin-, or IGF-I-treated FDC-P2 and insulin-stimulated CHO/IR/IRS-1 cells were immunoprecipitated (IP) with anti-p85, subjected
to SDS/PAGE, and immunoblotted with anti-phosphotyrosine (a-Ptyr). (B) The same lysates were immunoprecipitated with anti-
phosphotyrosine, and transferred proteins were immunoblotted with anti-p85.
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FIG. 5. Weak recognition of 4PS by an IRS-i-specific antibody.
(A) Lysates of IL-4- or insulin (INS)-treated FDC-P2 or insulin-
treated CHO/IR/IRS-1 cells were immunoprecipitated (IP) with
anti-phosphotyrosine (a-Ptyr) or anti-rat IRS-1, resolved by SDS/
PAGE, and immunoblotted with anti-phosphotyrosine. (B) Same
anti-phosphotyrosine immunoblot of anti-IRS-1 immunoprecipitates
as in A, except that the autoradiograph was exposed for 72 hr instead
of 24 hr.
indicate that 4PS and IRS-1 are not identical, the finding of
phosphopeptides ofcommon size and the weak recognition of
4PS by polyclonal anti-rat IRS-1 suggest that they may be
related to one another.
IL-4 Induces Tyrosine Phosphorylation of Rat IRS-1 in
FDC-Pl Cells Transfected with an IRS-1 Expression Vector. To
more fully investigate the relationship between insulin- and
IL-4-mediated signals, we sought to determine whether IL-4
could induce tyrosine phosphorylation of the protein encoded
by the cloned IRS-1 gene in the FDC background. An expres-
sion vector containing rat IRS-1 was introduced into the
FDC-P1 line by electroporation. Bands of 170 kDa were
readily detected in lysates of IL-4- and insulin-treated FDC-
Pl/IRS-i cells after immunoprecipitation with anti-IRS-i fol-
lowed by immunoblot analysis with anti-phosphotyrosine
(Fig. 6B). The relative amount of tyrosine-phosphorylated
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FIG. 6. Detection of tyrosine-phosphorylated IRS-1 in response
to IL-4 or insulin (INS) stimulation of the FDC-Pl/IRS-1 transfec-
tant. (A) Lysates from factor-stimulated FDC-Pl/IRS-1 or CHO/
IR/IRS-1 cells were immunoprecipitated (IP) and subsequently
immunoblotted with anti-phosphotyrosine (a-Ptyr). (B) Identical
lysates were immunoprecipitated with anti-rat IRS-1 and immuno-
blotted with anti-phosphotyrosine.
ognized in FDC-P1/IRS-1 lysates was equivalent to that
observed in the CHO/IR/IRS-1 lysate (Fig. 6). These results
imply that IRS-1 can be efficiently phosphorylated on tyrosine
in response to IL-4 or insulin stimulation in the FDC hema-
topoietic cell background.
DISCUSSION
The results demonstrate that IL-4, insulin, and IGF-I each
induce pronounced tyrosine phosphorylation of a 170-kDa
substrate in murine IL-3-dependent myeloid progenitor cell
lines. We have also observed tyrosine phosphorylation of a
170-kDa substrate in megakaryocytic, mast cell, and B lym-
phoid lines in response to IL-4, insulin, or IGF-I treatment
and in lipopolysaccharide-stimulated B cells and Con A-stim-
ulated T cells after treatment with IL-4 (unpublished work).
Thus, IL-4 and insulin induce similar tyrosine phosphoryla-
tion events in very different hematopoietic cell lineages.
Interestingly, the concentrations of both IL-4 and insulin
required to detect phosphorylation of and PI 3-kinase asso-
ciation with 4PS correlated precisely with those needed to
evoke DNA synthesis (data not shown), suggesting that this
substrate may play a crucial role in hematopoietic cell signal
transduction.
Our results indicate that the 170-kDa protein phosphory-
lated in response to insulin and IGF-I in the FDC lines is
identical to that phosphorylated in response to IL-4. The
substrate strongly associated with the 85-kDa subunit of PI
3-kinase after stimulation with each factor. Moreover, the
phosphopeptide patterns generated by V8 digestion of the
170-kDa proteins were identical to each other. Thus, it
appears that IL-4, insulin, and IGF-I activate tyrosine ki-
nases in FDC cells (and presumably other hematopoietic-
lineage cells) which phosphorylate an identical substrate,
4PS. The results obtained suggest that 4PS is probably related
to but not identical to IRS-1. While antibodies directed
against amino- and carboxyl-terminal peptides of rat/mouse
IRS-1 did not recognize 4PS (data not shown), a polyclonal
antibody directed against the entire rat IRS-1 protein was
able to weakly detect 4PS. V8 digestion of 4PS and IRS-1
generated some peptides with similar mobilities and others
which were distinct. Although 4PS and IRS-1 do not appear
to be identical proteins, IL-4 was able to induce readily
detectable tyrosine phosphorylation of rat IRS-1 expressed in
the FDC-P1/IRS-1 transfectant. Thus, the tyrosine kinase
activated by IL-4 stimulation is capable of phosphorylating
IRS-1, just as insulin or IGF-I receptor activation can medi-
ate tyrosine phosphorylation of 4PS. These results suggest
that 4PS and IRS-1 may be encoded by evolutionarily related
genes which are preferentially expressed in different cell
types and may play similar functional roles in signal trans-
duction.
To date, no other factor has been shown to induce phos-
phorylation of 4PS or IRS-1. While IL-3 stimulated pro-
nounced tyrosine phosphorylation of several substrates in the
FDC lines, it did not detectably phosphorylate 4PS (5). We
have recently observed weak IL-3-induced phosphorylation
of an -170-kDa protein in certain cell lines. Whether this
substrate is related to 4PS remains to be determined. Other
cytokines whose receptors are members of the hematopoietin
superfamily, including granulocyte/macrophage-colony-
stimulating factor, IL-2, IL-7, and erythropoietin, have also
been reported to induce tyrosine phosphorylation in various
cell lines (28-33). However, no substrate in the 170-kDa size
range was described in any of these studies. These results
suggest that the tyrosine kinase activated by IL-4 stimulation
differs from those most commonly induced by other cyto-
kines.
An important question which arises from this study is how
IL-4-mediated signaling leads to the tyrosine phosphoryla-
Cell Biology: Wang et al.
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tion of 4PS. In contrast to insulin and IGF-I receptors, the
IL-4 receptor possesses no known tyrosine kinase domain
(2-4, 34, 35). A previous study demonstrated that tyrosine
residues found in the YXXM motifs of IRS-1 were excellent
substrates for an activated insulin receptor kinase (16). Thus,
it is likely that activated insulin or IGF-I receptors directly
phosphorylate 4PS in the FDC lines. It is tempting to spec-
ulate that IL-4 might channel its signal by transactivating
either insulin or IGF-I receptor tyrosine kinases. While we
were able to observe insulin-dependent insulin receptor au-
tophosphorylation in the FDC lines, IL-4 treatment did not
detectably affect this receptor (data not shown). Thus, it is
more likely that IL-4 induces phosphorylation of 4PS by
activating an independent tyrosine kinase.
Although our results provide evidence that IL-4, insulin,
and IGF-I share similarities in some of the biological and
biochemical cascades they induce in the FDC lines, it re-
mains to be determined whether these factors activate other
overlapping signaling events. Insulin has been demonstrated
to stimulate tyrosine phosphorylation of mitogen-activated
protein kinase, phosphorylation ofRaf kinase, and activation
of the cellular Ras protein (36-41). By contrast, others have
reported that IL-4 does not affect any of these critical
signaling molecules (42-45). Thus, it seems likely that IL-4
and insulin signaling cascades share some coincident and
other divergent elements that account for their distinct phys-
iological roles.
We thank Charles Knicley and Jennifer Artrip for excellent
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